Navigation Links
Immunosuppressive Action Of Fungal Metabolite - Gliotoxin

Researchers from Japan have recently demonstrated the first evidence that mast cell is a direct target of gliotoxin.

Fungal secondary metabolites such as gliotoxin, an epipolythiodioxopiperazine toxin produced by pathogenic fungi like Candida and Aspergillus//, possess immunosuppressive activities and have been thought to contribute to pathology of fungal infections in animals and humans.

Mast cells play a key role in host defense and are important both for innate and adaptive immunity, and so, these findings suggest that suppression of mast cell activation might contribute to the establishment of infections for the pathogenic gliotoxin-producing fungi. Since recent studies show that mast cell plays a crucial role in the front of host defense, researchers examined whether fungal secondary metabolites affected mast cell activation.

Their study findings appear in the journal Clinical Immunology (available online 6 October 2005) The researchers found that gliotoxin had suppressive effects on mast cell activation, including degranulation, leukotriene C4 secretion, and TNF-á and IL-13 production. Gliotoxin also suppressed intracellular Ca2+ rise through store-operated Ca2+ channels with a minimal effect on depletion of internal Ca2+ stores.

Finally, gliotoxin induced intracellular production of superoxide possibly through a thiol redox cycling, which appeared to mediate suppressive effects on mast cell activation.
'"/>




Page: 1

Related medicine news :

1. Immunosuppressive drug shows promise in treatment of eye disorder
2. A Newly Identified Immunosuppressive Protein in Rheumatoid Arthritis
3. Action of nerve cells
4. Herbs With Estrogen Action Aggravate Cancer Risk
5. Legal Action against Authority Regarding Outbreak of Legionnaires’ Diseas
6. Mode Of Action Of The Anti-Convulsant Valproate
7. Action Plan Against Drug Deaths Launched
8. Ramadoss to Take Severe Action against Fertility Clinics Conducting Stem Cell Therapy
9. UN Formulates Action Plan for Relief to Recovery in Quake-hit Areas of Pakistan
10. HIV Infected Body Parts Stolen: Biomedical Tissue Services To Face Legal Action
11. India to Implement National Action Plan against TB-HIV
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2017)... ... 26, 2017 , ... Want to learn more about CRISPR-Cas ... that demonstrates how this advanced plant breeding technology is a more efficient way ... resources. It highlights the business’ principles, research and collaboration efforts in this area. ...
(Date:4/26/2017)... ... April 26, 2017 , ... MYOLYN, a medical ... that it has received 510(k) clearance from the U.S. Food & Drug Administration ... Pro. , Both devices are stationary cycling systems that use MYOLYN’s patent-pending ...
(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab ... to be the preferred physical therapy provider for Derby City CrossFit, effective immediately. ... City CrossFit as quickly and effectively as possible, ProRehab’s sports physical therapists will ...
(Date:4/25/2017)... IN (PRWEB) , ... April 25, 2017 , ... ... D.C., CEOs, CFOs and HR decision-makers are preparing for how his administration could ... Financial will provide insight into what changes are most likely to make it ...
(Date:4/25/2017)... ... , ... Lake Park Dental is now accepting new patients with crooked teeth ... With the help of this highly-effective, yet convenient system, patients can straighten their teeth ... less pain. , Drs. Sarah Jockin, Nicole Morganti, Sara Spear and Elizabeth Dy, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... ZappRx, Inc ., a digital health company focused on modernizing ... closed $25 million in Series B funding led by Qiming ... Seattle that is part of a broader ... round included participation from SR One , who led ... (formerly Google Ventures). As part of the financing, Mark ...
(Date:4/20/2017)... April 20, 2017 Eyevensys, a ... first non-viral gene expression technology that enables the safe, ... to address a wide range of ophthalmic diseases, announces ... Healthcare products Regulatory Agency (MHRA) to advance its technology ... ...
Breaking Medicine Technology: